ACUR OTC
Acura Pharmaceuticals, Inc.
1W: -1.0%
1M: -0.0%
3M: -88.9%
YTD: -80.0%
1Y: -75.0%
3Y: -99.8%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$860K
-50.5% ▼
5Y CAGR: -36.3%
Total Liabilities
$682K
-91.1% ▼
5Y CAGR: -37.3%
Shareholders Equity
$178K
+103.0% ▲
5Y CAGR: -31.5%
Cash & Investments
$65K
-84.3% ▼
5Y CAGR: -52.5%
Total Debt
$200K
-96.8% ▼
5Y CAGR: -48.2%
Net Debt
$135K
-97.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2M | $91K | $862K | $413K | $65K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $2M | $91K | $862K | $413K | $65K |
| Net Receivables | $71K | $204K | $194K | $627K | $158K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $149K |
| Total Current Assets | $3M | $461K | $1M | $1M | $372K |
| Property, Plant & Equip. | $679K | $606K | $540K | $484K | $438K |
| Goodwill & Intangibles | $1M | $1M | $810K | $73K | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $135K | $68K | $34K | $0 | $50K |
| Total Non-Current Assets | $2M | $2M | $1M | $557K | $488K |
| Total Assets | $5M | $2M | $3M | $2M | $860K |
| — Liabilities — | |||||
| Accounts Payable | $3K | $605K | $237K | $31K | $192K |
| Short-Term Debt | $3M | $0 | $0 | $6M | $33K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $254K | $275K | $44K | $19K |
| Total Current Liabilities | $5M | $1M | $1M | $8M | $515K |
| Long-Term Debt | $0 | $4M | $6M | $105K | $150K |
| Other Non-Current Liab. | $0 | $110K | $229K | $0 | $0 |
| Total Non-Current Liabilities | $0 | $4M | $6M | $105K | $167K |
| Total Liabilities | $5M | $6M | $7M | $8M | $682K |
| — Equity — | |||||
| Common Stock | $208K | $210K | $213K | $216K | $651K |
| Retained Earnings | -$380M | -$384M | -$388M | -$389M | -$390M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | -$27K | -$4M | -$5M | -$6M | $178K |
| Total Liabilities & Equity | $5M | $2M | $3M | $2M | $860K |
| — Key Metrics — | |||||
| Total Debt | $3M | $4M | $6M | $6M | $200K |
| Net Debt | $474K | $4M | $5M | $6M | $135K |
| Total Investments | $0 | $0 | $0 | $0 | $0 |